Medical Strategist - Oncology

Syneos Health is seeking a Medical Strategist - Oncology to join their team.

The Medical Strategist is responsible for delivering medical and scientific contributions across clinical development programs and strategic partnerships.

Responsibilities:

• Serve as the medical lead in multidisciplinary teams responding to RFPs, contributing to study design, indication strategy, and operational feasibility assessments.
• Provide therapeutic and medical insight during bid defense meetings and client consultations.
• Collaborate with business development and operational teams to ensure that proposed solutions align with client goals, budgets, and timelines.
• Lead the development of clinical trial protocols, medical monitoring plans, and other key deliverables.
• Ensure the scientific accuracy and regulatory compliance of medical content and clinical strategies.
• Act as a key point of contact for medical and strategic questions throughout the proposal and trial lifecycle.
• Build strong working relationships with clients, acting as a trusted advisor and ensuring high-quality service delivery.
• Bring deep subject matter expertise in at least one therapeutic area (e.g., Oncology, Rare Diseases, CNS, Infectious Diseases).
• Champion the integration of innovative technologies and methodologies (e.g., decentralized trials, adaptive design, digital biomarkers).

Requirements:

• Medical degree (MD, DO, or equivalent); additional training (PhD, MPH, MBA) is advantageous.
• 10–15 years of relevant experience in clinical research, with at least 5 years in a CRO or client-facing strategic role.
• Strong knowledge of ICH-GCP guidelines, clinical trial design, and global regulatory requirements.
• Demonstrated experience in therapeutic strategy, protocol development, and medical review.
• Proven ability to collaborate effectively with business development teams and present to clients.
• Excellent communication and interpersonal skills, with the ability to simplify complex scientific information for diverse audiences.
• Fluency in written and spoken English is essential. Travel up to 60% may be required.